Vestal Point Capital »

Sutro Biopharma shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 243k 11.57

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Kynam Capital Management
Vanguard Group
Acadian Asset Management
Velan Capital Investment Management
Vestal Point Capital
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
BlackRock
GSA Capital Partners
Marshall Wace

View all funds holding Sutro Biopharma